Martine A. Rothblatt, Chairperson & CEO at UNITED THERAPEUTICS Corp (UTHR), sold 9,500 shares at $542.06 ($5.2M) on 2026-10-02, disclosed to the SEC on 2026-10-05.
Scheduled sale ($5.2M) by Chairperson & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $542.06 | 700 | $379K | 7.3% |
| 2 | $542.87 | 408 | $221K | 4.2% |
| 3 | $544.17 | 1,032 | $562K | 10.8% |
| 4 | $544.90 | 1,280 | $697K | 13.4% |
| 5 | $546.75 | 309 | $169K | 3.2% |
| 6 | $547.99 | 1,171 |
| $642K |
| 12.3% |
| 7 | $548.87 | 1,206 | $662K | 12.7% |
| 8 | $549.59 | 757 | $416K | 8.0% |
| 9 | $550.99 | 432 | $238K | 4.6% |
| 10 | $551.82 | 725 | $400K | 7.7% |
| 11 | $552.86 | 160 | $88K | 1.7% |
| 12 | $554.30 | 80 | $44K | 0.8% |
| 13 | $555.60 | 80 | $44K | 0.9% |
| 14 | $557.43 | 240 | $134K | 2.6% |
| 15 | $558.60 | 120 | $67K | 1.3% |
| 16 | $560.66 | 120 | $67K | 1.3% |
| 17 | $562.35 | 40 | $22K | 0.4% |
| 18 | $563.88 | 80 | $45K | 0.9% |
| 19 | $566.58 | 80 | $45K | 0.9% |
| 20 | $569.90 | 240 | $137K | 2.6% |
| 21 | $570.70 | 120 | $68K | 1.3% |
| 22 | $572.44 | 80 | $46K | 0.9% |
| 23 | $574.23 | 40 | $23K | 0.4% |
| Total | $549.37 avg | 9,500 | $5.2M | 100% |
| Filing → |
| UTHR | SELL | 2026-10-14 | $5.2M | — | Filing → |
| UTHR | SELL | 2026-10-13 | $5.2M | — | Filing → |
| UTHR | SELL | 2026-10-13 | $5.2M | — | Filing → |